Human sVCAM-1 FlowCytomix Simplex

Also known as: Vascular cell adhesion protein 1, CD106 antigen

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# BMS8232/2FF*

Cat. No. Size
BMS8232/2FF 96 tests
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Human sVCAM-1 FlowCytomix Simplex.

Click on image to view more information.

  • Data for Human sVCAM-1 FlowCytomix Simplex.
Description

Description: This FlowCytomix Simplex Kit is designed for the measurement of Human sVCAM-1 in an immunoassay analyzed on a flow cytometer. Together with the FlowCytomix Human Basic Kit (cat. BMS8420FF), this kit can be used to detect sVCAM-1 alone or can be multiplexed with other Simplex Kits to measure a variety of analytes.

This kit contains bead population B5.

gnostic use. Not for use in therapeutic procedures.

The vascular cell adhesion molecule-1 (VCAM-1) or CD106 is a member of the immunoglobulin gene superfamily. The initial molecular cloning of VCAM-1 reported six extracellular Ig-like domains (6D VCAM-1). This 6D VCAM-1 arises due to alternative splicing from a seven-domain VCAM-1 (7D VCAM-1). 7D VCAM-1 is the dominant form expressed by cultured human endothelial cells. Domains 1 through 3 are highly homologous to domains 4 through 6, suggesting that they arose by gene duplication. VCAM-1 is not constitutively expressed on endothelium, but can be upregulated in vitro in response to LPS, TNF-a, and IL-1, as well as to IFN-gamma and IL-4. VCAM-1 is also present on tissue macrophages, dendritic cells, bone marrow fibroblasts, myoblasts and myotubes.

A soluble form of VCAM-1 (sVCAM-1) has been described. Soluble VCAM-1 levels have been found in the serum of healthy individuals and increased levels of sVCAM-1 can be detected in several diseases.

Cancer: ovarian, gastric-intestinal, renal, bladder cancer, non-Hodgkin's lymphoma, breast cancer (cyst fluid).

Autoimmune diseases: multiple sclerosis (cerebrospinal fluid), systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis.

Infections: sepsis, meningitis, malaria.

Inflammation: vasculitis, alcoholic cirrhosis, primary biliary cirrhosis, Wegener's granulomatosis.

Details
Reactivity Human
Sample Volume 25 uL (1:20 prediluted)
Suitable Sample Types cell culture supernatant, serum, plasma (EDTA, citrate)
Sensitivity 0.9 ng/mL
Standard Curve Range 3.0 - 2,000 ng/mL
Components 1 vial (175 ul) Fluorescent Beads (20x) coated with monoclonal antibody to human sVCAM-1, Bead Population B5
2 vials human sVCAM-1 Standard (lyophilized): 40 ug/ml upon reconstitution
1 vial (350 ul) Biotin-Conjugate (20x) anti-human sVCAM-1 monoclonal antibody
Reported Applications Multiplex Immunoassay
Documentation
TDS Link Download TDS
Related Products
Cat. No. Name Excite Emit Application Reg.
88-7439 Human IL-13 ELISA Ready-SET-Go!® ELISA RUO
BMS205* Human sE-selectin Platinum ELISA ELISA RUO
BMS810FFRTU* Human Th1/Th2 11plex Ready-to-Use FlowCytomix Multiplex Multiplex RUO
BMS812FF* Human Adhesion 6plex FlowCytomix Multiplex Multiplex RUO
References

Citations: Wang,J.; Zhang,S.; Jin,Y.; Qin,G.; Yu,L.; Zhang,J.. Elevated levels of platelet-monocyte aggregates and related circulating biomarkers in patients with acute coronary syndrome. Int J Cardiol. 2007;115:361-365. (Link)

Wong,C.K.; Ho,A.W.; Tong,P.C.; Yeung,C.Y.; Chan,J.C.; Kong,A.P.; Lam,C.W.. Aberrant expression of soluble co-stimulatory molecules and adhesion molecules in type 2 diabetic patients with nephropathy. J Clin Immunol 2008;28:36-43. (Link)

Michlmayr A.,S.Baumann,M.Zellner,C.Burghuber,P.Schuch,C.Wenzel,R.Bartsch,U.Pluschnig,I.Rech-Weichselbraun,G.Steger,R.Jakesz,M.Gnant and T.Bachleitner-Hofmann,M.Bergmann,R.Oehler. Chemotherapy induces inflammatory response in breast cancer patients. Keystonesymposia, Inflammation, Microenvironment and Cancer 2008;

References: Mason,J.C.; Kapahi,P.; Haskard,D.O.. Detection of increased levels of circulating intercellular adhesion molecule 1 in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus. Lack of correlation with levels of circulating vascular cell adhesion molecule 1. Arthritis Rheum. 1993;36:519-527. (Link)

Banks,R.E.; Gearing,A.J.; Hemingway,I.K.; Norfolk,D.R.; Perren,T.J.; Selby,P.J.. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br.J.Cancer 1993;68:122-124. (Link)

Ryan,D.H.; Nuccie,B.L.; Abboud,C.N.; Winslow,J.M.. Vascular cell adhesion molecule-1 and the integrin VLA-4 mediate adhesion of human B cell precursors to cultured bone marrow adherent cells. J.Clin.Invest 1991;88:995-1004. (Link)

Cybulsky,M.I.; Fries,J.W.; Williams,A.J.; Sultan,P.; Davis,V.M.; Gimbrone,M.A.,Jr.; Collins,T.. Alternative splicing of human VCAM-1 in activated vascular endothelium. Am.J.Pathol. 1991;138:815-820. (Link)

Fortis,C.; Galli,L.; Consogno,G.; Citterio,G.; Matteucci,P.; Scaglietti,U.; Bucci,E.. Serum levels of soluble cell adhesion molecules (ICAM-1, VCAM-1, E-selectin) and of cytokine TNF-alpha increase during interleukin-2 therapy. Clin.Immunol.Immunopathol. 1995;76:142-147. (Link)

Lim,A.G.; Jazrawi,R.P.; Levy,J.H.; Petroni,M.L.; Douds,A.C.; Maxwell,J.D.; Northfield,T.C.. Soluble E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in primary biliary cirrhosis. J.Hepatol. 1995;22:416-422. (Link)

Bechtel,U.; Scheuer,R.; Landgraf,R.; Konig,A.; Feucht,H.E.. Assessment of soluble adhesion molecules (sICAM-1, sVCAM-1, sELAM-1) and complement cleavage products (sC4d, sC5b-9) in urine. Clinical monitoring of renal allograft recipients. Transplantation 1994;58:905-911. (Link)

Gearing,A.J.; Hemingway,I.; Pigott,R.; Hughes,J.; Rees,A.J.; Cashman,S.J.. Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann.N Y.Acad.Sci. 1992;667:324-331. (Link)

Lai,L.C.; Siraj,A.K.; Kadory,S.; Lennard,T.W.. Concentrations of soluble vascular cell adhesion molecule-1 and E-selectin in breast cyst fluid and their relation with cyst type. Br.J.Surg. 1995;82:83-85. (Link)

Jakobsen,P.H.; Morris-Jones,S.; Ronn,A.; Hviid,L.; Theander,T.G.; Elhassan,I.M.; Bygbjerg,I.C.; Greenwood,B.M.. Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity. Immunology 1994;83:665-669. (Link)

Lobb,R.R.; Chi-Rosso,G.; Leone,D.R.; Rosa,M.D.; Bixler,S.; Newman,B.M.; Luhowskyj,S.; Benjamin,C.D.; Dougas,I.G.; Goelz,S.E.; .. Expression and functional characterization of a soluble form of endothelial-leukocyte adhesion molecule 1. J.Immunol. 1991;147:124-129. (Link)

Hession,C.; Tizard,R.; Vassallo,C.; Schiffer,S.B.; Goff,D.; Moy,P.; Chi-Rosso,G.; Luhowskyj,S.; Lobb,R.; Osborn,L.. Cloning of an alternate form of vascular cell adhesion molecule-1 (VCAM1). J.Biol.Chem. 1991;266:6682-6685. (Link)

Dore-Duffy,P.; Newman,W.; Balabanov,R.; Lisak,R.P.; Mainolfi,E.; Rothlein,R.; Peterson,M.. Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity. Ann.Neurol. 1995;37:55-62. (Link)

Carlos,T.M.; Schwartz,B.R.; Kovach,N.L.; Yee,E.; Rosa,M.; Osborn,L.; Chi-Rosso,G.; Newman,B.; Lobb,R.; .. Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood 1990;76:965-970. (Link)

Hession,C.; Moy,P.; Tizard,R.; Chisholm,P.; Williams,C.; Wysk,M.; Burkly,L.; Miyake,K.; Kincade,P.; Lobb,R.. Cloning of murine and rat vascular cell adhesion molecule. Biochem.Biophys.Res.Commun. 1992;183:163-169. (Link)

Lang,T.; Krams,S.M.; Villanueva,J.C.; Cox,K.; So,S.; Martinez,O.M.. Differential patterns of circulating intercellular adhesion molecule-1 (cICAM-1) and vascular cell adhesion molecule-1 (cVCAM-1) during liver allograft rejection. Transplantation 1995;59:584-589. (Link)

Rice,G.E.; Munro,J.M.; Bevilacqua,M.P.. Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes. A CD11/CD18-independent adhesion mechanism. J.Exp.Med. 1990;171:1369-1374. (Link)

Osborn,L.; Hession,C.; Tizard,R.; Vassallo,C.; Luhowskyj,S.; Chi-Rosso,G.; Lobb,R.. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989;59:1203-1211. (Link)

Williams,A.J.; Atkins,R.C.; Fries,J.W.; Gimbrone,M.A.,Jr.; Cybulsky,M.I.; Collins,T.. Nucleotide sequence of rat vascular cell adhesion molecule-1 cDNA. Biochim.Biophys.Acta 1992;1131:214-216. (Link)

Freedman,A.S.; Munro,J.M.; Morimoto,C.; McIntyre,B.W.; Rhynhart,K.; Lee,N.; Nadler,L.M.. Follicular non-Hodgkin's lymphoma cell adhesion to normal germinal centers and neoplastic follicles involves very late antigen-4 and vascular cell adhesion molecule. Blood 1992;79:206-212. (Link)

Wellicome,S.M.; Kapahi,P.; Mason,J.C.; Lebranchu,Y.; Yarwood,H.; Haskard,D.O.. Detection of a circulating form of vascular cell adhesion molecule-1: raised levels in rheumatoid arthritis and systemic lupus erythematosus. Clin.Exp.Immunol. 1993;92:412-418. (Link)

Spronk,P.E.; Bootsma,H.; Huitema,M.G.; Limburg,P.C.; Kallenberg,C.G.. Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study.. Clin.Exp.Immunol. 1994;97:439-444. (Link)

Sharar,S.R.; Winn,R.K.; Harlan,J.M.. The adhesion cascade and anti-adhesion therapy: an overview. Springer Semin.Immunopathol. 1995;16:359-378. (Link)

Mrowka,C.; Sieberth,H.G.. Detection of circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in Wegener's granulomatosis, systemic lupus erythematosus and chronic renal failure. Clin.Nephrol. 1995;43:288-296. (Link)

Masinovsky,B.; Urdal,D.; Gallatin,W.M.. IL-4 acts synergistically with IL-1 beta to promote lymphocyte adhesion to microvascular endothelium by induction of vascular cell adhesion molecule-1. J.Immunol. 1990;145:2886-2895. (Link)